TESARO, Inc.
(NASDAQ : TSRO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.34%195.371.2%$486.66m
GILDGilead Sciences, Inc.
-1.58%71.200.9%$439.20m
BIIBBiogen Inc.
-0.78%313.071.3%$342.01m
ILMNIllumina, Inc.
-3.74%305.373.5%$328.61m
CELGCelgene Corporation
-1.54%79.371.2%$318.83m
VRTXVertex Pharmaceuticals Incorporated
-3.04%172.001.9%$229.07m
REGNRegeneron Pharmaceuticals, Inc.
-2.11%379.602.6%$219.24m
ALXNAlexion Pharmaceuticals, Inc.
-2.00%121.452.0%$213.77m
SRPTSarepta Therapeutics, Inc.
-2.26%129.5616.4%$162.22m
AAgilent Technologies, Inc.
-3.83%61.821.5%$149.00m
BMRNBioMarin Pharmaceutical Inc.
-4.38%99.004.4%$133.28m
LGNDLigand Pharmaceuticals Incorporated
-3.21%178.9523.3%$114.41m
EXASExact Sciences Corporation
-2.14%60.9225.3%$103.32m
ECYTEndocyte, Inc.
-0.09%23.502.1%$95.77m
NBIXNeurocrine Biosciences, Inc.
-2.48%106.465.1%$93.32m

Company Profile

TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.